DHT and Hair Loss: What's Actually Happening

If you're a man losing hair, there's a good chance DHT is involved. Dihydrotestosterone — a potent androgen derived from testosterone — is the primary hormonal driver of male pattern baldness in genetically susceptible men. It doesn't cause hair loss in everyone, but in men with the relevant receptor sensitivity, it triggers a slow, progressive process of follicle miniaturization that's been well-documented for decades.

This site covers the biology clearly, reviews what the research actually shows about blocking DHT, and compares your options without overselling any of them. The goal is to help you understand what's happening and make an informed decision — not to push you toward a purchase.

What Is a DHT Blocker? Key Terms Defined

Understanding DHT-related hair loss starts with knowing what the core terms actually mean. Here are the definitions that matter:

DHT (Dihydrotestosterone)

What is DHT? DHT is defined as a potent androgen hormone formed when the enzyme 5-alpha-reductase converts testosterone. DHT refers to dihydrotestosterone specifically — the androgen responsible for miniaturizing hair follicles in men with androgenetic alopecia. It is approximately 3–5 times more potent than testosterone at binding to androgen receptors (Imperato-McGinley et al., Journal of Clinical Endocrinology & Metabolism, 1992).

DHT Blocker

What is a DHT blocker? A DHT blocker is defined as any compound — natural or pharmaceutical — that reduces the production or biological activity of dihydrotestosterone. DHT blockers work through two primary mechanisms: inhibiting 5-alpha-reductase (the enzyme that converts testosterone to DHT) or blocking androgen receptors so DHT cannot bind to follicle cells. The term refers to both prescription drugs like finasteride and natural compounds like saw palmetto extract.

5-Alpha-Reductase (5-AR)

5-alpha-reductase refers to the enzyme family responsible for converting testosterone into DHT. Two isoforms are relevant: Type 1 (found in skin and liver) and Type 2 (concentrated in scalp follicles and prostate tissue). Most DHT-blocking treatments target one or both isoforms to reduce DHT levels at the follicle.

Androgenetic Alopecia

What is androgenetic alopecia? Androgenetic alopecia is defined as the medical term for hereditary pattern hair loss driven by androgen hormones — primarily DHT. It refers to the progressive miniaturization of hair follicles in genetically susceptible individuals, affecting an estimated 50% of men by age 50 (American Academy of Dermatology, 2023).

Follicle Miniaturization

Follicle miniaturization refers to the progressive shrinking of hair follicles under sustained DHT exposure. Terminal hairs (thick, pigmented) gradually transform into vellus hairs (fine, colorless, barely visible). Once fully miniaturized, a follicle is generally considered non-recoverable by DHT-blocking interventions alone.